Mini Review
Volume 9 Issue 12 - 2020
Molecular Determinants of Isoniazid Drug Resistance Mycobacterium tuberculosis
Z Saifutdinov*, N Shadmanova, N Parpieva, V Antonenka and L Tu
National Reference Laboratory, Republican Scientific and Practical Center of Phthisiology and Pulmonology, Tashkent, Uzbekistan
*Corresponding Author: Z Saifutdinov, National Reference Laboratory, Republican Scientific and Practical Center of Phthisiology and Pulmonology, Tashkent, Uzbekistan.
Received: November 06, 2020; Published: November 25, 2020




Abstract

Drug-resistant TB (TB) is a serious global problem, not only complicates the treatment of patients with resistant strains of TB, but also poses a threat to the global process to achieve the goals of the TB elimination strategy in the world by the World Health Organization (WHO) [1]. WHO estimates that 1.674 million people died of tuberculosis in 2016 alone, while between 2000 and 2016 they were healed 52.5 million lives thanks to improved diagnosis and treatment. At the same time, 13 of the 22 highest burden countries failed to meet the target for the decline in tuberculosis prevalence in 2014, highlighting the need to improve strategies to combat the disease [2]. Effective TB control is especially challenging among patients with multidrug-resistant TB (MDR-TB), which are resistant to at least isoniazid and rifampicin, the two most potent anti-TB drugs used in standard first-line treatment. For example, 2015 data show that by the end of 2014, 153 countries had reported the circulation of drug-resistant TB strains in the region, eighty of which have continuous surveillance systems, while others rely on epidemiological surveys. In the absence of an effective vaccine against tuberculosis, appropriate antibiotic therapy remains the most important tool in the fight against the spread of tuberculosis. N on at the same time, the factors of resistance, greatly exacerbating transmission from TB that are resistant to the first drug and the second line and show the importance of broader molecular genetic research in this area [1-5].

Keywords: Tuberculosis; Drug Resistance; Molecular Mechanisms of Development of Mycobacterial Resistance; Gene Mutations

References

  1. World Health Organization. WHO Consolidated Guidelines on Drug Resistant Tuberculosis Treatment. Geneva, Switzerland: WHO (2019).
  2. Global tuberculosis report. World Health Organization, Geneva, Switzerland (2017).
  3. World Health Organization. Global Tuberculosis Report (2018).
  4. Forrellad MA., et al. “Virulence factors of the Mycobacterium tuberculosis complex”. Virulence 1 (20013): 3-66.
  5. Nguyen L. “Antibiotic resistance mechanisms in M. tuberculosis an update”. Archives of Toxicology 90 (2016): 1585-604.
  6. Savinova AA and Usanina LV. “The mechanisms of antibiotic resistance of Mycobacterium tuberculosis”. International Student Scientific Bulletin (2017): 6.
  7. Chernyaeva EN. “Biochemical mechanisms of drug resistance of Mycobacterium tuberculosis”. Saint Petersburg State University Bulletin 2 (2012): 77-91.
  8. Jagielski T., et al. “Mutation profiling for detection of isoniazid resistance in Mycobacterium tuberculosis clinical isolates”. Journal of Antimicrobial Chemotherapy 70 (2015): 3214-3221.
  9. Jagielski T., et al. “Identification and analysis of mutations in the katG gene in multidrug-resistant Mycobacterium tuberculosis clinical isolates”. Pneumonologia i Alergologia Polska 81 (2013): 298-307.
  10. Zhang Y., et al. “The catalase-β-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis”. Nature 358 (1992): 591-593.
  11. Timmins GS and Deretic V. “Mechanisms of action of isoniazid”. Molecular Microbiology 62 (2006): 1220-1227.
  12. Seifer M., et al. “Genetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis: a systematic review”. PloS one 10 (2015): e0119628.
  13. Böttger EC. In Antituberculosis Chemotherapy Volume 40 (eds PR Donald and PD van Helden) Chapter 14 (2011): 128-144.
  14. Vilcheze C and Jacobs WR. “Resistance to isoniazid and ethionamide in Mycobacterium tuberculosis: genes, mutations, and causalities”. Microbiology Spectrum 2 (2013).
  15. Pauline Lempens., et al. “Isoniazid resistance levels of Mycobacterium tuberculosis can largely be predicted by high confidence resistance-conferring Mutations”. Scientific Reports 8 (2018): 3246.
  16. Coll F., et al. “Genome-wide analysis of multi-and extensively drug-resistant Mycobacterium tuberculosis”. Nature Genetics 50 (2018): 307.
  17. Demay C., et al. “SITVITWEB - a publicly available international multimarker database for studying Mycobacterium tuberculosis genetic diversity and molecular epidemiology”. Infection, Genetics and Evolution 4 (2012): 755-766.
  18. Liu L., et al. “The impact of combined gene mutations in inhA and ahpC genes on high levels of isoniazid resistance amongst katG non-315 in multidrug-resistant tuberculosis isolates from China”. Emerg Microbes Infect1 (2018): 183.
  19. Brossier F., et al. “Comparison of a semiautomated commercial repetitive-sequence-based PCR method with spoligotyping, 24-locus mycobacterial interspersed repetitive-unit-variable-number tandem-repeat typing, and restriction fragment length polymorphism-based analysis of IS6110 for Mycobacterium tuberculosis typing”. Journal of Clinical Microbiology 11 (2014): 4082-4086.
  20. Zhdanova SN., et al. “Epidemiological substantiation of the distribution of the main clones of the Beijing Mycobacterium tuberculosis genotype in the Irkutsk region”. Journal Mikrobiol Ogii 6 (2017): 88-94.
  21. Casali N., et al. “Evolution and transmission of drug-resistant tuberculosis in a Russian population”. Nature Genetics 3 (2014): 279-286.
  22. De Keijzer J., et al. “Disclosure of selective advantages in the "modern" sublineage of the 134 Mycobacterium tuberculosis Beijing genotype family by quantitative proteomics”. Molecular and Cellular Proteomics 10 (2014): 2632-2645.
  23. VV Sinkov. "Molecular-epidemiological analysis of experimental data on the example of the genotype". Beijing "(Beijing) Mycobacterium tuberculosis (2012).
  24. Surkova LK., et al. “Molecular genetic characteristics of the causative agent of tuberculosis: relationship with the prevalence, course and outcome of the disease. Vesti National Academy of Sciences of Belarus”. Gray Medytsyn Navuk 4 (2016): 114-125.
  25. Bostanabad ZS., et al. “KatG mutations in isoniazid-resistant strains of Mycobacterium tuberculosis isolates from Belarusian patients”. Tuberkuloz ve Toraks 3 (2007): 231-237.
  26. Dymova MA., et al. “Molecular genetic characteristics of M. tuberculosis effluents in patients with pulmonary tuberculosis in Astana”. SB RAMS Bulletin1 (2011): 107-112.
  27. Akhmetova AZh., et al. “Molekulyarnaya characteristic multiresistant strains of M. tuberculosis , circulating in Kazakhstan”. Science and Health21 (2019): 45-52.
  28. C Allen., et al. “Molekulyarno - genetic analysis and cn e CTD mutations in genes katG, inhA, rpo B, encoding drug resistance to isoniazid and rifampicin in patients with tuberculosis and HIV infection”. Tuberculosis and Lung Diseases8 (2016): 54-59.
  29. Hasker E., et al. “The practice of prescribing anti-tuberculosis drugs in Uzbekistan”. International Journal of Tuberculosis and Lung Diseases1 (2011): 135-142.
Citation: Z Saifutdinov., et al. “Molecular Determinants of Isoniazid Drug Resistance Mycobacterium tuberculosis”. EC Pulmonology and Respiratory Medicine 9.12 (2020): 63-68.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


January Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the January issue of respective journals and can be viewed in the current issue pages.

Submission Deadline for January Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the January issue of respective journals. Submissions are accepted on/before January 26, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk